34,598 public posts
Want to take advantage of all our features? Just log in!
or
Nottingham health and well being event
we look forward to seeing you,
Lorraine @ Roy Castle Lung Cancer Foundation
Please join INHERIT Study
Our goals are to learn more about:
-Inherited or genetic risk for developing lung cancer in certain people or families
-Changes in lung cancer tumors in people with increased genetic risk
-Ways to better predict lung cancer risk for certain groups of people
Who can join the INHERIT Study?
New approval for treatment of Small Cell Lung Cancer (SCLC)
FDA Approves Imdelltra (tarlatamab-dlle) for Extensive Stage Small Cell Lung Cancer
Written by colleague, Matthew Reiss, MSE, PhD, Manager, Precision Medicine & Navigation, GO2 for Lung Cancer
On May 16, 2024, the U.S.
Share your experience of early-stage non-small cell lung cancer
Have you had surgery or radiotherapy for early-stage non-small cell lung cancer within the past year?
Did you have you cancer treatment in England?
Are you available to take part in a 1-hour interview online, by phone or in person?
Please join us next Tuesday, October 15th, for our Living Room discussion on Treating EGFR Mutated Non-Small Cell Lung Cancer
Join us for a conversation on how new targeted therapies and a greater understanding of tumor biology have advanced treatments for EGFR-mutated non-small cell lung cancer (NSCLC). First-generation targeted therapy drugs outperformed traditional chemotherapy, but new mutations led to resistance.
Media request - London biopsy experience
Ideally we wanted to speak with a lung cancer patient who had some complications following a physical biopsy but also speaking in general with someone affected by lung cancer would be ok. We would do this interview sometime on Monday if possible."